SMLR

Semler Scientific Inc

Healthcare Medical Devices

Portfolio

Watchlist

None USD 0.00(0%)

Last update at 2026-01-29T21:00:55.608105Z

Market Cap

164.78M

P/E

8.39

Momentum Score

…

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range

20.88

Low

53.38

High

Momentum Score

…

Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close

20.33

Dividend Yield

Revenue TTM

65.88M

Revenue Per Share

9.72

Gross Profit TTM

52.43M

Debt / Equity

0.00

ROE

31.18%

Net Debt

-57.13M

ROCE

23.94%

Diluted EPS TTM

2.78

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Income before tax	17.69M	19.45M	16.49M	10.70M	5.04M
Net income	14.32M	17.22M	14.01M	15.08M	5.01M
Selling general administrative	12.74M	9.23M	6.41M	6.95M	4.16M
Selling and marketing expenses	17.68M	14.45M	9.94M	8.96M	7.20M
Gross profit	52.43M	46.91M	35.25M	29.11M	18.79M
Reconciled depreciation	0.59M	0.63M	0.58M	0.63M	0.50M
Ebit	17.20M	18.82M	15.38M	10.71M	4.83M
Ebitda	17.79M	19.45M	15.96M	10.70M	5.34M
Depreciation and amortization	0.59M	0.63M	0.58M	-0.01M	0.50M
Non operating income net other	-0.01M	-	0.51M	-0.01M	-0.00M
Operating income	17.20M	19.45M	15.96M	10.71M	5.34M
Other operating expenses	39.48M	33.58M	22.64M	22.06M	16.15M
Interest expense	-0.49M	0.64M	1.10M	0.00M	0.30M
Tax provision	3.37M	2.23M	2.48M	-4.38M	0.03M
Interest income	0.49M	0.01M	0.08M	0.00M	-
Net interest income	0.49M	0.01M	0.08M	0.00M	-0.30M
Income tax expense	3.37M	2.23M	2.48M	-4.38M	0.03M
Total revenue	56.69M	53.03M	38.60M	32.77M	21.49M
Total operating expenses	35.23M	27.46M	19.29M	18.40M	13.45M
Cost of revenue	4.25M	6.12M	3.36M	3.66M	2.70M
Total other income expense net	0.49M	0.01M	0.53M	-0.01M	-0.00M
Net income from continuing ops	14.32M	17.22M	14.01M	15.08M	5.01M
Net income applicable to common shares	14.32M	17.22M	14.01M	15.08M	5.01M

Breakdown	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Total assets	78.06M	62.69M	50.67M	34.64M	18.29M
Other current assets	2.17M	1.47M	8.21M	4.18M	3.70M
Total liab	6.27M	7.02M	5.12M	4.85M	5.21M
Total stockholder equity	71.80M	55.68M	45.55M	29.79M	13.07M
Other current liab	4.59M	4.78M	3.44M	0.08M	3.91M
Common stock	0.01M	0.01M	0.01M	0.01M	0.01M
Capital stock	0.01M	0.01M	0.01M	0.01M	0.01M
Retained earnings	59.80M	39.22M	24.89M	7.67M	-6.33M
Other liab	-	0.16M	-	0.33M	0.01M
Other assets	0.00M	5.14M	5.14M	5.06M	4.52M
Cash	57.20M	23.01M	37.32M	22.08M	7.74M
Total current liabilities	6.20M	6.86M	4.88M	4.51M	5.21M
Current deferred revenue	1.12M	1.16M	0.92M	0.96M	0.95M
Net debt	-57.13M	-22.77M	-37.00M	-22.08M	-7.74M
Short term debt	0.09M	0.09M	0.08M	2.80M	-
Short long term debt total	0.07M	0.24M	0.33M	-	-
Other stockholder equity	11.98M	16.45M	20.64M	22.11M	19.40M
Property plant equipment	-	2.48M	1.64M	0.26M	0.25M
Total current assets	65.94M	48.91M	45.54M	26.26M	11.44M
Long term investments	5.88M	5.50M	0.82M	3.05M	-
Net tangible assets	-	55.68M	45.55M	29.79M	13.07M
Short term investments	0.00M	20.07M	-	-	-
Net receivables	6.12M	3.88M	3.62M	2.81M	3.49M
Inventory	0.45M	0.47M	0.55M	-2.81M	-3.49M
Accounts payable	0.40M	0.83M	0.44M	0.68M	0.34M
Accumulated other comprehensive income	-	-	-	-	-1.68M
Common stock total equity	-	0.01M	0.01M	0.01M	0.01M
Retained earnings total equity	-	39.22M	24.89M	7.67M	-6.33M
Non currrent assets other	0.27M	2.84M	0.33M	0.42M	0.01M
Non current assets total	12.12M	13.79M	5.14M	8.38M	6.84M
Capital lease obligations	0.16M	0.24M	0.33M	-	-

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Investments	-24.68M	-0.82M	1.94M	-1.70M	-0.84M
Change to liabilities	1.89M	0.28M	-0.49M	1.17M	-0.28M
Total cashflows from investing activities	-26.84M	-0.82M	-1.31M	-1.70M	-0.84M
Net borrowings	-	-	-	-	-2.90M
Total cash from financing activities	-4.94M	0.01M	0.23M	-6.57M	-2.03M
Change to operating activities	1.56M	-2.06M	-2.40M	1.05M	-0.11M
Net income	14.32M	17.22M	14.01M	15.08M	5.01M
Change in cash	-14.31M	15.24M	14.34M	4.46M	1.83M
Begin period cash flow	37.32M	22.08M	7.74M	3.28M	1.46M
End period cash flow	23.01M	37.32M	22.08M	7.74M	3.28M
Total cash from operating activities	17.46M	16.06M	15.42M	12.73M	4.70M
Issuance of capital stock	-	-	-	-	0.00M
Depreciation	0.59M	0.63M	0.58M	0.63M	0.50M
Other cashflows from investing activities	-	-	-2.19M	-1.94M	0.00M
Change to inventory	0.08M	-1.41M	-2.40M	1.05M	-0.11M
Change to account receivables	-0.37M	-0.87M	0.62M	-0.73M	-1.50M
Sale purchase of stock	-4.99M	0.06M	-0.25M	-6.57M	0.87M
Other cashflows from financing activities	-0.11M	0.01M	0.48M	-6.57M	0.87M
Change to netincome	0.96M	2.78M	2.71M	-3.88M	0.85M
Capital expenditures	2.16M	0.82M	1.06M	1.70M	0.84M
Change receivables	-0.37M	-0.87M	0.62M	-0.73M	-1.50M
Cash flows other operating	-0.01M	-2.57M	-2.01M	0.46M	-0.14M
Cash and cash equivalents changes	-14.31M	15.24M	14.34M	4.46M	1.83M
Change in working capital	1.67M	-4.58M	-1.43M	0.89M	-1.92M
Stock based compensation	0.74M	0.75M	0.25M	0.36M	0.60M
Other non cash items	0.49M	1.63M	-0.13M	0.25M	0.25M
Free cash flow	15.30M	15.23M	14.36M	11.03M	3.85M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
ABT Abbott Laboratories	-0.71 0.65%	108.58	25.97	17.24	3.57	3.20	3.81	16.75
MDT Medtronic PLC	0.28 0.28%	101.89	26.60	15.87	3.35	2.08	3.90	14.12
SYK Stryker Corporation	-2.16 0.68%	316.63	29.23	16.86	4.18	4.51	4.63	17.16
SEMHF Siemens Healthineers AG	- -%	47.31	39.57	21.32	3.01	3.29	2.95	16.92

Profile*

Semler Scientific Inc

Address

2340-2348 Walsh Avenue, Santa Clara, CA, United States, 95051

Contact

(877) 774-4211

Website

https://www.semlerscientific.com

Employees

Name	Title	Year Born
Dr. Douglas Murphy-Chutorian M.D.	CEO, Corp. Sec. & Director	1954
Mr. Andrew B. Weinstein	Sr. VP of Fin. & Accounting	1964
Dr. Herbert J. Semler	Founder & Chairman Emeritus	1928
Mr. Robert G. McRae	Chief Technical Officer	1969
Mr. Dennis Rosenberg	Chief Marketing Officer	1954
Ms. Renae Cormier	CFO, Principal Accounting Officer, Head of Corp. Communications & Bus. Strategy and Secretary	1973
Dr. Douglas Murphy-Chutorian M.D.	CEO, President & Director	1954
Ms. Jennifer Oliva Herrington	Chief Operating Officer	NA
Mr. Shane Reid	Chief Technology Officer	NA
Ms. Cindy Guinasso	Senior Vice President of Business Development	NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

Top Gainers*
Top Losers*

Equity Sectors*

Basic Materials

-1.70%
Communication Services

+0.33%
Consumer Cyclical

+0.45%
Consumer Defensive

-0.56%
Energy

-0.25%
Financial Services

+0.49%
Healthcare

+0.20%
Industrials

+0.74%
Real Estate

+1.71%
Technology

-2.81%
Utilities

+0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

TYT	GBX 3102.38 +3.03%
CPG	GBX 33.81 -1.11%
DGED	GBX 93.25 -1.26%
LTOD	GBX 37.75 -1.44%
KNM	GBX 24500.00 +2.04%

DAR	GBX 8.30 +23.42%
VTY	GBX 276.20 +8.23%
GTCO	GBX 0.09 +6.98%
GLV	GBX 2.34 +6.36%
BUR	GBX 249.20 +5.95%

TMI	GBX 0.72 -6.49%
HSBA	GBX 1291.40 -5.42%
RKT	GBX 5218.00 -4.85%
TGA	GBX 643.00 -4.03%
RKH	GBX 61.70 -3.89%